(2023). Retracted: Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer. Computational and Mathematical Methods in Medicine.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Retracted: Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer."
Computational and Mathematical Methods in Medicine 2023.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Retracted: Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer."
Computational and Mathematical Methods in Medicine, 2023.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.